IA
VIR icon

IFP Advisors’s Vir Biotechnology VIR Stock Holding History

IFP Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67K Buy
556
+445
+401% +$4.23K ﹤0.01% 3703
2026
Q1 		$995 Buy
111
+58
+109% +$462 ﹤0.01% 4219
2025
Q4 		$320 Sell
53
-86
-62% -$512 ﹤0.01% 4390
2025
Q3 		$794 Sell
139
-370
-73% -$1.89K ﹤0.01% 4027
2025
Q2 		$2.57K Buy
+509
New +$2.73K ﹤0.01% 3782
2025
Q1 		– Sell
-219
Closed -$1.95K – 3824
2024
Q4 		$1.86K Buy
219
+19
+10% +$150 ﹤0.01% 3130
2024
Q3 		$1.5K Hold
200
– – ﹤0.01% 2994
2024
Q2 		$1.78K Hold
200
– – ﹤0.01% 2834
2024
Q1 		$2.03K Hold
200
– – ﹤0.01% 2687
2023
Q4 		$2.01K Sell
200
-161
-45% -$1.47K ﹤0.01% 2676
2023
Q3 		$3.38K Buy
361
+161
+81% +$2.3K ﹤0.01% 2662
2023
Q2 		$4.91K Hold
200
– – ﹤0.01% 2552
2023
Q1 		$2.8K Sell
200
-23
-10% -$588 ﹤0.01% 2786
2022
Q4 		$4K Buy
223
+23
+12% +$564 ﹤0.01% 3943
2022
Q3 		$3K Hold
200
– – ﹤0.01% 4272
2022
Q2 		$3K Hold
200
– – ﹤0.01% 4037
2022
Q1 		$3K Hold
200
– – ﹤0.01% 4037
2021
Q4 		$8K Hold
200
– – ﹤0.01% 2316
2021
Q3 		$9K Sell
200
-391
-66% -$16.9K ﹤0.01% 2337
2021
Q2 		$27K Sell
591
-75
-11% -$3.41K ﹤0.01% 1800
2021
Q1 		$33K Buy
666
+60
+10% +$3.23K ﹤0.01% 1624
2020
Q4 		$15K Buy
606
+135
+29% +$4.39K ﹤0.01% 1913
2020
Q3 		$16K Buy
471
+271
+136% +$11.7K ﹤0.01% 1739
2020
Q2 		$7K Hold
200
– – ﹤0.01% 1965
2020
Q1 		$6K Buy
+200
New +$5.38K ﹤0.01% 2013

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IFP Advisors's VIR Position: Q2 2026 in Review

IFP Advisors increased its Vir Biotechnology (VIR) stake by 401% in Q2 2026, buying an estimated $4.23K and bringing the position to 556 shares worth $5.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3703.

IFP Advisors first reported a position in VIR in Q1 2020 and has held it in 25 quarters since. The position peaked at $33K in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • IFP Advisors held 556 shares of Vir Biotechnology worth $5.67K as of Q2 2026.
  • IFP Advisors bought 445 Vir Biotechnology shares in Q2 2026, an estimated $4.23K.
  • Vir Biotechnology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3703 holding.
  • IFP Advisors first reported a position in Vir Biotechnology in Q1 2020 and has held it in 25 quarters since.
  • IFP Advisors's Vir Biotechnology position peaked at $33K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.